From the Food and Drug Administration.
Nightingale
S L
SL
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D015507:Drugs, Investigational / Q000627:therapeutic use*; D005515:Food Labeling / Q000331:legislation & jurisprudence; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000627:therapeutic use*; D010264:Paraplegia / Q000534:rehabilitation*; D019736:Prostheses and Implants; D014481:United States; D014486:United States Food and Drug Administration; D014747:Vinblastine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077235:Vinorelbine
D000970:Antineoplastic Agents; D015507:Drugs, Investigational; D014747:Vinblastine; D017239:Paclitaxel; D000077235:Vinorelbine